Peter M Neupert, Director, on August 17, 2026, sold 124,690 shares in Adaptive Biotechnologies (ADPT) for $3,135,850. Following the Form 4 filing with the SEC, Neupert has control over a total of 130,625 common shares of the company, with 130,625 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1478320/000123756626000003/xslF345X05/primary_doc.xml